カイノスの株価時系列
| 日付 | 始値 | 高値 | 安値 | 終値 | 前日比 | 騰落率 | 出来高 |
|---|---|---|---|---|---|---|---|
| 2025/06/16 | 1,243 | 1,243 | 1,240 | 1,241 | +7 | +0.6% | 500 |
| 2025/06/13 | 1,241 | 1,241 | 1,232 | 1,234 | -6 | -0.5% | 300 |
| 2025/06/12 | 1,231 | 1,240 | 1,231 | 1,240 | -1 | -0.1% | 500 |
| 2025/06/11 | 1,237 | 1,241 | 1,233 | 1,241 | +4 | +0.3% | 700 |
| 2025/06/10 | 1,235 | 1,237 | 1,235 | 1,237 | +2 | +0.2% | 300 |
| 2025/06/09 | 1,240 | 1,241 | 1,235 | 1,235 | -5 | -0.4% | 1,800 |
| 2025/06/06 | 1,236 | 1,240 | 1,236 | 1,240 | +8 | +0.6% | 500 |
| 2025/06/05 | 1,224 | 1,232 | 1,223 | 1,232 | -5 | -0.4% | 900 |
| 2025/06/04 | 1,237 | 1,237 | 1,236 | 1,237 | +10 | +0.8% | 700 |
| 2025/06/03 | 1,235 | 1,237 | 1,224 | 1,227 | -8 | -0.6% | 1,700 |
| 2025/06/02 | 1,212 | 1,235 | 1,212 | 1,235 | +12 | +1% | 500 |
| 2025/05/30 | 1,221 | 1,230 | 1,201 | 1,223 | -12 | -1% | 3,600 |
| 2025/05/29 | 1,223 | 1,235 | 1,222 | 1,235 | +12 | +1% | 1,500 |
| 2025/05/28 | 1,225 | 1,237 | 1,223 | 1,223 | -9 | -0.7% | 1,300 |
| 2025/05/27 | 1,230 | 1,240 | 1,230 | 1,232 | +2 | +0.2% | 300 |
| 2025/05/26 | 1,237 | 1,237 | 1,230 | 1,230 | -6 | -0.5% | 800 |
| 2025/05/23 | 1,250 | 1,250 | 1,236 | 1,236 | -14 | -1.1% | 700 |
| 2025/05/22 | 1,254 | 1,254 | 1,238 | 1,250 | +2 | +0.2% | 500 |
| 2025/05/21 | 1,226 | 1,288 | 1,226 | 1,248 | +18 | +1.5% | 4,800 |
| 2025/05/20 | 1,250 | 1,250 | 1,230 | 1,230 | -15 | -1.2% | 1,700 |
| 2025/05/19 | 1,247 | 1,247 | 1,233 | 1,245 | +12 | +1% | 1,300 |
| 2025/05/16 | 1,237 | 1,240 | 1,230 | 1,233 | -23 | -1.8% | 1,100 |
| 2025/05/15 | 1,249 | 1,260 | 1,247 | 1,256 | +7 | +0.6% | 1,700 |
| 2025/05/14 | 1,248 | 1,249 | 1,248 | 1,249 | +1 | +0.1% | 300 |
| 2025/05/13 | 1,248 | 1,248 | 1,241 | 1,248 | -1 | -0.1% | 700 |
| 2025/05/12 | 1,250 | 1,255 | 1,241 | 1,249 | +14 | +1.1% | 1,900 |
| 2025/05/09 | 1,255 | 1,264 | 1,235 | 1,235 | -17 | -1.4% | 3,300 |
| 2025/05/08 | 1,235 | 1,252 | 1,235 | 1,252 | -5 | -0.4% | 600 |
| 2025/05/07 | 1,230 | 1,257 | 1,230 | 1,257 | +26 | +2.1% | 1,000 |
| 2025/05/02 | 1,239 | 1,239 | 1,211 | 1,231 | +4 | +0.3% | 1,200 |
| 2025/05/01 | 1,265 | 1,265 | 1,227 | 1,227 | -38 | -3% | 1,400 |
| 2025/04/30 | 1,247 | 1,292 | 1,200 | 1,265 | +18 | +1.4% | 40,900 |
| 2025/04/28 | 1,196 | 1,247 | 1,148 | 1,247 | +51 | +4.3% | 77,800 |
| 2025/04/25 | 1,191 | 1,196 | 1,149 | 1,196 | +22 | +1.9% | 1,500 |
| 2025/04/24 | 1,152 | 1,198 | 1,152 | 1,174 | +39 | +3.4% | 3,200 |
| 2025/04/23 | 1,140 | 1,149 | 1,135 | 1,135 | +6 | +0.5% | 600 |
| 2025/04/22 | 1,134 | 1,149 | 1,129 | 1,129 | -16 | -1.4% | 600 |
| 2025/04/21 | 1,136 | 1,146 | 1,135 | 1,145 | -12 | -1% | 2,400 |
| 2025/04/18 | 1,143 | 1,157 | 1,142 | 1,157 | +14 | +1.2% | 1,300 |
| 2025/04/17 | 1,156 | 1,156 | 1,142 | 1,143 | -15 | -1.3% | 400 |
| 2025/04/16 | 1,157 | 1,158 | 1,139 | 1,158 | +25 | +2.2% | 400 |
| 2025/04/15 | 1,118 | 1,158 | 1,118 | 1,133 | -6 | -0.5% | 600 |
| 2025/04/14 | 1,156 | 1,156 | 1,125 | 1,139 | -16 | -1.4% | 2,600 |
| 2025/04/11 | 1,140 | 1,165 | 1,140 | 1,155 | +15 | +1.3% | 3,600 |
| 2025/04/10 | 1,116 | 1,165 | 1,116 | 1,140 | +37 | +3.4% | 4,700 |
| 2025/04/09 | 1,109 | 1,132 | 1,103 | 1,103 | -7 | -0.6% | 3,700 |
| 2025/04/08 | 1,110 | 1,150 | 1,110 | 1,110 | +12 | +1.1% | 4,100 |
| 2025/04/07 | 1,049 | 1,132 | 1,035 | 1,098 | -86 | -7.3% | 10,600 |
| 2025/04/04 | 1,248 | 1,248 | 1,175 | 1,184 | -41 | -3.3% | 11,500 |
| 2025/04/03 | 1,230 | 1,235 | 1,220 | 1,225 | -11 | -0.9% | 3,700 |
1～
50
件表示中 / 3721件
類似銘柄と比較する
現在ご覧いただいている「カイノス」と類似性の高い銘柄をピックアップ。投資家が注目しているデータで比較できるようになっています。銘柄選びの参考情報としてご活用ください。
| 銘柄名 | 最低購入代金 | 売上高 成長率 |
経常 増益率 |
配当 利回り |
PER | PBR | 直近のチャート | 特色 |
|---|---|---|---|---|---|---|---|---|
| カイノス | 124,100円 | +3.7% | +2.7% | 2.58% | 8.72倍 | 0.77倍 |
|
臨床検査薬の中堅メーカー。生化学、免疫血清学的検査用試薬に重点。共同開発の促進に注力 |
| ＮＰＴ | - | - | - | - | - | - |
|
- |
| ＯＴＳ | 2,100円 | +33.3% | - | 0.00% | - | 8.79倍 |
|
がん治療ワクチン創薬ベンチャー。大手製薬と開発提携。東大医科研発。会社計画は非開示 |
| 免疫生物 | 51,500円 | +5.8% | +14.8% | 1.17% | 18.10倍 | 3.17倍 |
|
研究用試薬の製販・受託。遺伝子組み換えカイコの基礎研究は休止し、化粧品等応用開発に移行 |
| ＶＩＳ | 70,900円 | +306.2% | - | 0.00% | 27.37倍 | 2.08倍 |
|
ｍＲＮＡ標的低分子創薬技術を製薬会社に提供。共同創薬研究などによる契約金収入が柱 |
市場注目の銘柄
チャート関連のコラム
